OUR SERVICES

Endotype

Discovery

  • Traditionally, disease was defined based on symptom expression and treated using a one size fits all approach.

  • It is now recognized that many diseases are complex and heterogenous, comprising distinct molecular subtypes that are driven by discrete pathways.

  • Our team employs cutting-edge technologies that define disease endotypes on the basis of variations in the structure of biological networks, which function across multiple layers of regulation.

PERTH
AUSTRALIA

Nick Bosco

nick.bosco@insigene.com

 

ARIZONA
UNITED STATES

© 2021 Insigene Ltd. Site developed by NFIC Services.